The Lancet Oncology (LO)

The Lancet Oncology covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Topics include but are not limited to breast cancer; endocrine system cancer; gastrointestinal cancer; genitourinary cancer; gynaecological cancer; haematological cancer; head and neck cancer; neurooncology; paediatric oncology; thoracic oncology; sarcoma; skin cancer; epidemiology, cancer prevention, and cancer control; supportive care; imaging; and health-care systems. We have also fostered a reputation for hosting events for oncologists, cancer researchers, and policymakers, and convenes many conferences, either independently or in collaboration with partners. Events include branded plenary lectures and sessions at conferences worldwide: Asian Oncology Summit, The Lancet Summit: Cancer care in Asia and Latin America, Oncology At The Limits, Frontiers of Oncology, and Advancing Cancer Immunotherapy, to name just a few. We publish a range of article types that encompass all aspects of oncological medicine: Articles, Review, Policy Review, Personal View, Clinical Picture, Comment, Correspondence, News, and Perspectives. We also publish Series and Commissions (typically in partnership with societies, governments, NGOs, and academic centres) that aim to shape and drive positive change in clinical practice and health policy in areas of need in global oncology. Learn more about the types of papers we publish.

The Lancet Oncology (LO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, Medicine , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1470-2045, E-ISSN: 1474-5488, Established: 2000, Impact Factor: 51.1
• Provides Crossref DOI

• Indexed in: Scopus

• Not indexed in WoS, DOAJ, PubMed, UGC CARE